Aalborg University Hospital is the largest hospital in the North Denmark Region, Denmark. It is also northern Jutland's largest employer, with approximately 6,500 employees. The hospital consists of Section South and North in Aalborg and Dronninglund Hospital.

During the past decade, Aalborg University Hospital, Department of Cardiology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aalborg University Hospital, Department of Cardiology" #1 sponsor was "Idorsia Pharmaceuticals Ltd." with 2 trials, followed by "Aalborg University Hospital" with 1 trials sponsored, "Aarhus University Hospital Skejby" with 1 trials sponsored, "Cytokinetics" with 1 trials sponsored and "Rigshospitalet, Denmark" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aalborg University Hospital, Department of Cardiology" #1 collaborator was "Aalborg University" with 1 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator, "Ji Xing Pharmaceuticals (Shanghai) Co., Ltd." with 1 trials as a collaborator and "Karl G Andersens Fond" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Aalborg University Hospital, Department of Cardiology" are "Acute Myocardial Infarction" (1 trials), "Angina Pectoris" (1 trials), "Atrioventricular Block" (1 trials), "Coronary Heart Disease" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Aalborg University Hospital, Department of Cardiology" in a lesser frequency.

Most popular intervention types in "Aalborg University Hospital, Department of Cardiology" are "Device" (2 trials), "Drug" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials), "CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg)" (1 trials) and "COMBO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aalborg University Hospital, Department of Cardiology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Aalborg University Hospital, Department of Cardiology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Aalborg University Hospital, Department of Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aalborg University Hospital, Department of Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".